Success stories in molecular farming - a brief overview

Plant Biotechnology Journal

Volumn 8, Issue 5, 2010, Pages 525-528

  Faye, Loïc ^a   Gomord, Veronique ^a  

^a Loïc Faye and Veronique Gomord ANGANY Genetics ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; EDITORIAL; GENETIC ENGINEERING; PHARMACEUTICS; PUBLICATION; TRANSGENIC PLANT;

BIOTECHNOLOGY; GENETIC ENGINEERING; PERIODICALS AS TOPIC; PLANTS, GENETICALLY MODIFIED; TECHNOLOGY, PHARMACEUTICAL;

EID: 77954018329     PISSN: 14677644     EISSN: 14677652     Source Type: Journal    
DOI: 10.1111/j.1467-7652.2010.00521.x     Document Type: Editorial

References (16)

1. Boothe J, Nykiforuk C, Shen Y, Zaplachinski S, Szarka S, Kuhlman P, Murray E, Morck D, Moloney MM. Seed-based expression systems for plant molecular farming. Plant Biotechnol. J. 2010, 8:525-528.
2. D'Aoust M-A, Couture MM-J, Charland N, Trépanier S, Landry N, Ors F, Vézina L-P. The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza. Plant Biotechnol. J. 2010, 8:607-609.
3. De Muynck B, Navarre C, Boutry M. Production of antibodies in plants: status after twenty years. Plant Biotechnol. J 2010, 8:529-563.
4. Gomord V, Fitchette A-C, Menu-Bouaouiche L, Saint-Jore-Dupas C, Plasson C, Michaud D, Faye L. Plant-specific glycosylation patterns in the context of therapeutic protein production. Plant Biotechnol. J 2010, 8:564-587.
5. Hiatt A, Cafferkey R, Bowdish K. Production of antibodies in transgenic plants. Nature 1989, 342:76-78.
6. Huang N, Bethell D, Card C, Cornish J, Marchbank T, Wyatt D, Mabery K, Playford R. Bioactive recombinant human lactoferrin, derived from rice. In Vitro Cell. Dev. Biol. 2008, 44:464-471.
7. Ma JKC, Hikmat BY, Wycoff K, Vine ND, Chargelegue D, Yu L, Hein MB, Lherner T. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat. Med. 1998, 4:601-606.
8. Ma JK, Drake PM, Chargelegue D, Obregon P, Prada A. Antibody processing and engineering in plants, and new strategies for vaccine production. Vaccine 2005, 23:1814-1818.
9. Mason HS, Lam DM, Arntzen CJ. Expression of hepatitis B surface antigen in transgenic plants. Proc. Natl Acad. Sci. USA 1992, 89:11745-11749.
10. McCormick AA, Reddy S, Reinl SJ, Cameron TI, Czerwinkski DK, Vojdani F, Hanley KM, Garger SJ, White EL, Novak J, Barrett J, Holtz RB, Tuse D, Levy R. Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: safety and immunogenicity in a phase I clinical study. Proc. Natl Acad. Sci. USA 2008, 105:10131-10136.
11. Pogue GP, Vojdani F, Palmer KE, Hiatt E, Hume S, Phelps J, Long L, Bohorova N, Kim D, Pauly M, Velasco J, Whaley K, Zeitlin L, Garger SJ, White E, Bai Y, Haydon H, Bratcher B. Production of pharmaceutical-grade recombinant aprotinin and a monoclonal antibody product using plant-based transient expression systems. Plant Biotechnol. 2010, 8:638-654.
12. Rader RA. " (Re)defining biopharmaceutical" . Nat. Biotechnol. 2008, 26:743-751.
13. Ribicky EP. Plant-made vaccines for humans and animals. Plant Biotechnol. J 2010, 8:620-637.
14. Shaaltiel Y, Bartfeld D, Hashmueli S, Baum G, Brill-Almon E, Galili G, Dym O, Boldin-Adamsky SA, Silman I, Sussman JL, Futerman AH, Aviezer D. Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system. Plant Biotechnol. J. 2007, 5:579-590.
15. Thangaraj H, van Dolleweerd CJ, McGowan EG, Ma JK. Dynamics of global disclosure through patent and journal publications for biopharmaceutical products. Nat. Biotechnol. 2009, 27:614-618.
16. Zavaleta N, Figueroa D, Rivera J, Sanchez J, Alfaro S, Lonnerdal B. Efficacy of rice-based oral rehydration solution containing recombinant human lactoferrin and lysozyme in Peruvian children with acute diarrhea. J. Pediatr. Gastroenterol. Nutr. 2007, 44:258-264.